-
Drug Costs and Cancer CareExperts discuss the value of cancer treatments in a climate of rising drug prices.
by Kevin McLaughlin
-
What Is Hyper-Progression?Some researchers believe that immunotherapy occasionally causes cancer to grow faster, a phenomenon dubbed hyper-progression.
by Kate Yandell
-
Risk Reduction, Clinical Trials Are Focus of Atlanta Community EventCancer researchers, patient advocates and community members gathered for a public forum presented by the American Association for Cancer Research.
by Kevin McLaughlin
-
March 29: The Week in Cancer NewsJury awards damages to man who says Roundup caused his cancer, the FDA proposes national standards for breast density notifications, and a physician questions whether patients with impaired renal function should avoid contrast-enhanced scans.
by Marci A. Landsmann
-
Keeping an Eye on CancerImaging tests for post-treatment surveillance may come with radiation exposure, financial strain, “scanxiety” and sometimes unnecessary follow-ups. Doctors and patients need to balance the risks and benefits of scanning.
by Charlotte Huff
-
More Options for Rare CancersPrecision medicine and immunotherapy offer opportunities for new treatments and clinical trials to patients who previously had few, if any, options.
by Kendall K. Morgan
-
The Patient PerspectivePatient-reported outcomes may help shape the future of cancer care.
by Stephen Ornes
-
Healthy Habits
Power OffToo much time spent looking at electronic devices can come at a cost.
by Cameron Walker
-
Q&A
Hope Amid the HypeHematologist-oncologist David Scadden traces the history, promise and uncertainties of treatment advances in Cancerland: A Medical Memoir.
by Marci A. Landsmann
-
From the Editor-in-Chief
Why Are Liver Cancer Death Rates Up?Hepatitis C infection, obesity and alcohol can contribute to more cases of liver cancer.
by William G. Nelson, MD, PhD
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
Continuing the ConversationThe AACR hosts a roundtable to ‘get real’ about cancer health disparities.
by Marci A. Landsmann
More Patients Participating in Cancer ResearchA higher proportion of cancer patients are enrolling in research studies than previously thought, but many patients lack the access needed to participate.
by Kyle Bagenstose
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung CancerThe drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
-
What Is a Cancer Vaccine?Learn about cancer vaccines, including the various types used to treat or prevent cancer, and discover what's already available and what's on the horizon.
-
Chemtai Mungo, MD, MPH: Bringing Cervical Cancer Treatment to More WomenAn innovative self-treatment strategy for cervical precancer could save lives in low- and middle-income countries as well as underserved areas in the U.S.
Alexis Browning
